• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Schweiger Dermatology Group Acquires Windsor Dermatology in East Windsor, New Jersey

Share:

May 2, 2023

Schweiger Dermatology Group, the largest dermatology practice in the Northeast, has acquired Windsor Dermatology in East Windsor, New Jersey. The acquisition will enable Schweiger Dermatology Group to expand its reach to more patients with chronic skin conditions, thanks to Windsor Dermatology’s expertise in psoriasis and leadership in clinical trials. Drs. Jerry Bagel and David Nieves, founders of Windsor Dermatology, will remain on staff and continue to see patients at their current location. The acquisition marks Schweiger Dermatology Group’s 28th office location in New Jersey.

Schweiger Dermatology Group, the largest dermatology practice in the Northeast, has announced the acquisition of Windsor Dermatology in East Windsor, New Jersey. Windsor Dermatology, originally founded by Jerry Bagel, M.D. with David Nieves, M.D. joining on as a partner, is well known as a leader in medical dermatology and for high-quality clinical trials. Windsor Dermatology is also home to The Psoriasis Treatment Center of New Jersey, the state’s first complete facility for advanced psoriasis research and therapies.

“We are thrilled to welcome the Windsor Dermatology team to Schweiger Dermatology Group,” says Dr. Eric Schweiger, founder and C.E.O. of Schweiger Dermatology Group. “Their expertise in psoriasis and leadership in clinical trials will enable us to reach more patients with chronic skin conditions and help them achieve a better quality of life.”

“I am pleased to incorporate Windsor Dermatology’s clinical trial center of excellence into Schweiger Dermatology Group, offering access to more patients who are struggling with their atopic dermatitis and psoriasis or who cannot obtain medications,” says Dr. Bagel, a four-term member of the medical advisory board of the National Psoriasis Foundation.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Drs. Bagel and Nieves will remain on staff and continue to see patients at their current office location. In addition, Schweiger Dermatology Group welcomes Matthew Halpern, M.D., Wendy Myers, M.D., Jessica Simon, M.D., Brianna Butler, PA-C, Alexa Hetzel, PA-C, and Kristen Teixeira, PA-C to the practice. All providers will continue to see patients at the East Windsor office location, 59 One Mile Road, East Windsor, New Jersey. This marks Schweiger Dermatology Group’s 28th office location in the state of New Jersey.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer TherapeuticsSorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer Therapeutics
  • How AI Is Revolutionizing HealthcareHow AI Is Revolutionizing Healthcare
  • Highmark Health Begins Partnership with Google Cloud to Build up New Care Delivery ModelHighmark Health Begins Partnership with Google Cloud to Build up New Care Delivery Model
  • Biotherapeutics Startup Hummingbird Raises US$19M in Series B FundingBiotherapeutics Startup Hummingbird Raises US$19M in Series B Funding
  • Global COVID-19 Treatment Industry Top-Vendor And Industry Insights By End-User Segments Till 2027Global COVID-19 Treatment Industry Top-Vendor And Industry Insights By End-User Segments Till 2027
  • Thrive Earlier Detection Wins the Bluecross Blueshield Data Innovation ChallengeThrive Earlier Detection Wins the Bluecross Blueshield Data Innovation Challenge
  • OSF Ventures Joins $35M Funding Round for Handheld Ultrasound DeviceOSF Ventures Joins $35M Funding Round for Handheld Ultrasound Device
  • Royalty Boosts Struggling PTC with Additional $1B for Royalties on Roche’s EvrysdiRoyalty Boosts Struggling PTC with Additional $1B for Royalties on Roche’s Evrysdi

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications